TECHNOLOGY SUMMARY The technology consists in a vaccine which can be administrated through the mucosa (oral and/or intranasal) for the treatment and control of PCV2 associated diseases. Additionally, this vaccine includes a microencapsulated antigen, which permits to deliver an efficient and harmless immunization and also controlled delivery to the therapeutic target. This innovation also has […]